Zokinvy (lonafarnib) - Eiger
https://journals.lww.com/hep/fulltext/2023/10001/the_liver_meeting__boston,_massachusetts_nov.1.aspx
 
Christina Park1; Julian Hercun1; Harel Dahari2; Ohad Etzion3; Saeed S. Hamid4; Edward J. Gane5; Yoav Lurie6; Farial Rahman1; David Yardeni7; Pallavi Surana1; Colin Hislop8; Ingrid Choong8; Jeffrey Glenn9; Theo Heller10; Christopher Koh11; 1National Institutes of Health; 2The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA, Highland Park, IL; 3Saroka University Medical Center, Beer-Sheba, Israel, Beer-Shiva, Israel; 4Aga Khan University Hospital, Karachi, Pakistan; 5University of Auckland; 6Shaare Zedek Medical Center; 7Soroka University Medical Center, Mishmar Hanegev, Israel; 8Eiger BioPharmaceuticals, Inc.; 9Division of Gastroenterology and Hepatology, Departments of Medicine, Microbiology & Immunology, Stanford School of Medicine, Stanford, California, USA; 10Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 11National Institute of Diabetes and Digestive and Kidney Diseases, Nih
 
Oct 12, 2023
 
Prev Next